Subscribe for great stories in your community!
Conshohocken-based Madrigal Pharmaceuticals plans to raise $500 million while anticipating FDA approval of a groundbreaking therapy, writes John George for the Philadelphia Business Journal…
Madrigal Pharmaceuticals, West Conshohocken, has experienced a rapid rise in its stock price and market capitalization, which at the start of the week was at…
Before we send you to this site, please subscribe to our daily newsletter.